← Compare landing
iXCells Biotechnologies vs Scantox
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | iXCells Biotechnologies | Scantox |
|---|---|---|
| Summary | Offers iPSC reprogramming, CRISPR genome editing, directed differentiation, and in vitro bioassay and ASO screening services. Builds human iPSC-derived cellular models for preclinical drug discovery. | Preclinical CRO with a CNS/neurology focus, offering in vivo transgenic and induced disease models for Alzheimer's, Parkinson's, ALS, and Huntington's alongside in vitro assays for tau and α-synuclein aggregation, neuroinflammation, and neuronal plasticity. |
| Services |
|
|
| Modalities |
| Data not yet provided. |
| Indications |
|
|
| Phases |
|
|
| Sourcing models | Data not yet provided. | Data not yet provided. |
| Locations | Data not yet provided. | Data not yet provided. |
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/ixcells-biotechnology/scantox.md